AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.586
+0.016 (0.64%)
Sep 10, 2025, 3:10 PM - Market open

AIM ImmunoTech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
71321234593
Upgrade
Market Cap Growth
-67.29%-39.50%-5.77%-49.92%-51.57%-16.26%
Upgrade
Enterprise Value
990-13-842
Upgrade
Last Close Price
2.5719.8043.9931.1992.00179.00
Upgrade
PS Ratio
56.4175.79105.42160.27334.23571.61
Upgrade
PB Ratio
--9.742.080.590.791.52
Upgrade
P/TBV Ratio
--2.950.630.831.58
Upgrade
EV/Sales Ratio
72.6953.431.51--256.30
Upgrade
Debt / Equity Ratio
-0.43-2.220.070.020.000.04
Upgrade
Asset Turnover
0.010.010.010.000.000.00
Upgrade
Quick Ratio
0.080.421.6526.3574.1636.41
Upgrade
Current Ratio
0.100.441.6826.6974.6136.58
Upgrade
Return on Equity (ROE)
--388.69%-118.93%-40.79%-32.37%-38.54%
Upgrade
Return on Assets (ROA)
-104.62%-88.30%-66.64%-25.36%-17.44%-21.77%
Upgrade
Return on Capital (ROIC)
-362.96%-196.60%-79.38%-25.85%-17.68%-22.27%
Upgrade
Earnings Yield
-236.83%-134.44%-136.00%-86.05%-42.39%-15.46%
Upgrade
FCF Yield
-160.78%-115.70%-99.87%-71.66%-31.04%-11.15%
Upgrade
Buyback Yield / Dilution
-34.13%-15.30%-1.12%-1.49%-48.67%-774.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q